★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
GE HealthCare Technologies Inc. (GEHC) Moat Analysis
GE HealthCare Technologies Inc.
GEHC · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
GE HealthCare is a global medical-technology and pharmaceutical-diagnostics company with three current reportable segments: Advanced Imaging Solutions, Patient Care Solutions and Pharmaceutical Diagnostics. Q2 2026 segment revenue was 71.3% AIS, 12.8% PCS and 15.9% PDx. Operating-profit shares are omitted because PCS recorded a segment loss. The strongest advantages are global imaging service coverage, equipment-linked workflows, cross-modality scope and PCS installed-base consumables. In PDx, regulated manufacturing, contrast-media capacity and supply reliability matter; Q2 growth included both volume and price. GE HealthCare had 451,686,252 shares outstanding on July 22, 2026. Pressures include PCS operational and fulfillment problems, capital budgets, right-to-repair, interoperability, local competition, memory-chip and freight inflation, tariffs and procurement concessions.
Primary segment
Advanced Imaging Solutions (AIS)
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
3 segments · 7 tags
Updated 2026-08-23
Segments
Advanced Imaging Solutions (AIS)
Diagnostic imaging, specialized ultrasound and procedural-guidance equipment, software and lifecycle service (CT, MR, molecular imaging, X-ray, women's health and interventional systems)
Revenue
71.3%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Patient Care Solutions (PCS)
Patient monitoring, anesthesia and respiratory care, maternal-infant care, and diagnostic cardiology devices + consumables and clinical decision software
Revenue
12.8%
Structure
Oligopoly
Pricing
weak
Share
—
Peers
Pharmaceutical Diagnostics (PDx)
Contrast media and radiopharmaceutical imaging agents (and injectors) used in CT, MR, X-ray, ultrasound, SPECT/PET
Revenue
15.9%
Structure
Oligopoly
Pricing
strong
Share
—
Peers
Moat Claims
Advanced Imaging Solutions (AIS)
Diagnostic imaging, specialized ultrasound and procedural-guidance equipment, software and lifecycle service (CT, MR, molecular imaging, X-ray, women's health and interventional systems)
Q2 2026 AIS revenue was $3.771B of $5.289B total segment revenue and grew 7.9% year over year, including 5.0% organic growth. The Intelerad acquisition contributed to reported growth. AIS Segment EBIT was $525M, up 15.4%.
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Large installed base supported by a global field service organization; uptime-critical assets drive service contract attachment and parts revenue.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Right-to-repair regulations expanding third-party access
- Independent service organizations (ISOs) undercut OEM service pricing
- Increased remote diagnostics reducing differentiation of onsite service
Leading indicators
- Service contract attach rate
- Parts and service revenue growth vs. equipment shipments
- ISO penetration in key regions
Counterarguments
- Large hospitals may self-service or use ISOs for cost reasons
- Competitors (Siemens/Philips) also have large service networks
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Imaging software, AI applications, and data integration services embed GEHC into radiology workflows; lifecycle software upgrades reduce willingness to switch OEMs.
Data Workflow Lockin moat: definition, examples, and stocks
Erosion risks
- Open standards and vendor-neutral archives weaken lock-in
- Cloud-native imaging IT vendors displace incumbent stacks
- Interoperability mandates reduce switching frictions
Leading indicators
- Software subscription/ARR growth
- Renewal/retention rates for imaging IT
- Competitive win-loss vs. vendor-neutral archive / cloud PACS vendors
Counterarguments
- Radiology IT often interoperates across vendors (DICOM) so switching is feasible
- Hospitals may decouple software from hardware procurement
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
AIS combines radiology, specialized ultrasound and procedural guidance, allowing imaging, ultrasound and software capabilities to be reused across modalities and procedure-room offerings.
Scope Economies moat: definition, examples, and stocks
Erosion risks
- Modular best-of-breed systems displace integrated suites
- Open integration standards reduce ecosystem advantage
- Hospital consolidation strengthens bargaining power
Leading indicators
- Growth across CT, ultrasound and procedural-guidance product lines
- Software attach and subscription growth in AIS
- Service contract attachment rates for interventional systems
Counterarguments
- Large competitors also offer integrated interventional and imaging stacks
- Interoperability requirements can reduce lock-in
Patient Care Solutions (PCS)
Patient monitoring, anesthesia and respiratory care, maternal-infant care, and diagnostic cardiology devices + consumables and clinical decision software
Q2 2026 PCS revenue was $675M of $5.289B total segment revenue and declined 13.3% year over year because of operational and fulfillment challenges. Segment EBIT was a $26M loss. Management is reviewing strategic options to maximize the business's long-term value.
Installed Base Consumables
Demand
Installed Base Consumables
Strength
Durability
Confidence
Evidence
Monitoring fleets drive recurring revenue via proprietary parameters, sensors, and a broad catalog of consumables and service contracts.
Installed Base Consumables moat: definition, examples, and stocks
Erosion risks
- Third-party compatible disposables/sensors reduce OEM capture
- Hospital procurement standardization squeezes consumables pricing
- Device connectivity standards reduce proprietary parameter advantage
Leading indicators
- Consumables revenue growth vs. installed base growth
- Attach rate of disposable sensors/accessories per monitor
- Gross margin trends in consumables and service
Counterarguments
- Many consumables can be multi-sourced or standardized
- Competitors also bundle monitoring + disposables + service
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Clinical decision and workflow software aggregates device data across care settings, increasing integration and change-management costs for hospitals.
Data Workflow Lockin moat: definition, examples, and stocks
Erosion risks
- Vendor-neutral monitoring platforms integrated with EHRs displace point solutions
- Cybersecurity incidents reduce trust in connected platforms
- Interoperability requirements reduce switching costs
Leading indicators
- Software recurring revenue growth within PCS
- Renewal rates for monitoring data platforms
- Number of devices/sites connected per customer
Counterarguments
- Vendor-agnostic positioning can reduce lock-in compared with closed platforms
- Hospitals may standardize on EHR-native tooling
Pharmaceutical Diagnostics (PDx)
Contrast media and radiopharmaceutical imaging agents (and injectors) used in CT, MR, X-ray, ultrasound, SPECT/PET
Q2 2026 PDx revenue was $843M of $5.289B total segment revenue and grew 15.6% year over year, driven by volume and price in contrast media and radiopharmaceuticals. Segment EBIT was $250M, up 16.9%; management said the first-half supplier issue was resolved.
Supply Chain Control
Supply
Supply Chain Control
Strength
Durability
Confidence
Evidence
Reliable, timely global supply of contrast media and radiopharmaceuticals is critical; capacity, logistics, and quality systems create operational barriers and customer preference for dependable suppliers.
Supply Chain Control moat: definition, examples, and stocks
Erosion risks
- Manufacturing disruptions (quality issues, plant outages)
- Input constraints (APIs, radioisotopes) and logistics shocks
- Government price controls or tender reforms
Leading indicators
- Backorder rates and reported shortages
- Capacity expansions and ramp milestones (e.g., new fill-finish lines)
- Regulatory inspection outcomes and warning letters
Counterarguments
- Large competitors also invest in global manufacturing networks
- Customers may multi-source to reduce supplier dependency
Compliance Advantage
Legal
Compliance Advantage
Strength
Durability
Confidence
Evidence
Strict regulation and lifecycle monitoring (marketing authorizations, pharmacovigilance, inspections) raise barriers to entry and favor scaled incumbents with mature quality systems.
Compliance Advantage moat: definition, examples, and stocks
Erosion risks
- Regulatory changes increasing cost or delaying launches
- Safety concerns driving labeling restrictions or product withdrawal
Leading indicators
- Time-to-approval for new agents
- Regulatory enforcement actions in the category
- Product recall frequency and severity
Counterarguments
- Regulatory compliance is table-stakes for all incumbents; not uniquely proprietary
- Regulators can impose sudden constraints that hurt incumbents too
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
Combination of imaging equipment, agents, cyclotrons, and advanced visualization software enables integrated offerings and R&D leverage across modalities/disease states.
Scope Economies moat: definition, examples, and stocks
Erosion risks
- Antitrust scrutiny or bundling restrictions
- Customers prefer best-of-breed sourcing across vendors
Leading indicators
- Cross-selling wins (equipment + agents + software)
- New product launches that span hardware + agent workflows
Counterarguments
- Agents are often used across multiple OEM imaging platforms, limiting bundle lock-in
- Regulators and procurement may resist bundled purchasing
Evidence
a global team of approximately 9,700 sales professionals and 8,900 field service engineers
Shows scale of GEHC service footprint supporting uptime and lifecycle service revenue.
extensive network of field service engineers, global repair centers
Supports existence of an extensive service network and highlights competitive/right-to-repair pressure as an erosion risk.
upgradable through the lifecycle of the equipment
Evidence that lifecycle software and applications remain attached to imaging equipment after purchase.
drive connectivity across healthcare systems
Supports workflow integration across the product lifecycle.
advanced X-ray imaging that integrates with ultrasound and other imaging and diagnostic systems
Supports complementarity and integration across modalities.
Showing 5 of 15 sources.
Risks & Indicators
Erosion risks
- Right-to-repair regulations expanding third-party access
- Independent service organizations (ISOs) undercut OEM service pricing
- Increased remote diagnostics reducing differentiation of onsite service
- Open standards and vendor-neutral archives weaken lock-in
- Cloud-native imaging IT vendors displace incumbent stacks
- Interoperability mandates reduce switching frictions
Leading indicators
- Service contract attach rate
- Parts and service revenue growth vs. equipment shipments
- ISO penetration in key regions
- Regulatory momentum on right-to-repair
- Software subscription/ARR growth
- Renewal/retention rates for imaging IT
Research GEHC elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.